See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Insulin Resistance

Page 2
Mayo Clinic Says Simple Lifestyle Changes Can Forestall Type 2
Sep 4, 2012 | 
The Mayo Clinic Health Letter for August 2012 has published three lifestyle changes that could stave off the progression of prediabetes to full-blown type 2 diabetes. The list isn't new, but its periodic reiteration indicates that healthcare researchers and providers have settled on a simple prescription for staying diabetes-free.
US Sale of Generic Actos Gets FDA Nod
Aug 27, 2012 | 
The Food and Drug Administration has approved US sale of generic pioglitazone (trade name Actos) for the treatment of type 2 diabetes. Actos, originally developed and trademarked by Takeda Pharmaceuticals, works by decreasing insulin resistance in type 2 patients. The prescription drug, which belongs to the class of drugs known as thiazolidinediones (TZDs), has enjoyed great commercial success in the United States since its introduction in 1999, posting estimated sales last year of $2.7 billion.
DHTV
Popular
Top Rated

Related Complications & Care Videos on Diabetes Health TV

Medi-Peds® Comforting Therapeutic Socks and Shoes

Robb Sackett, Senior V.P. Sales and Marketing

Medi-Peds® Comforting Therapeutic Socks and Shoes

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week


Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54